Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.05 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 4 Parkinson's papers of 1,007 | 0.79 |
| pathways Reactome | 9 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 4996
Sealed predictions
- SAA1 in dopamine neurons, braak-0.16 (p 0.680) → -0.55 (p 0.121)receipt 5003
Swarm cases
receipt 5003: SAA1 in dopamine neurons, braak
- power
- full sample -0.35 (p 0.150, n 18), 95% CI -0.70 to +0.14. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.37 (p 0.127, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.50 (p 0.034, n 18). not the mix.
- skeptic
- leave-one-out range -0.47 to -0.27, sign flips 0; without severely affected donors -0.35 (p 0.150, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SAA1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts